782041008: Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)

• SNOMED CT Concept\produit pharmaceutique ou biologique\Medicinal product (product)\...
• \Medicinal product categorized by disposition (product)\inhibiteur enzymatique\Product containing hydrolase inhibitor (product)\Product containing phosphodiesterase inhibitor (product)\Product containing papaveretum (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Papaveretum and scopolamine only product\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Medicinal product categorized by disposition (product)\inhibiteur enzymatique\Product containing hydrolase inhibitor (product)\Product containing phosphodiesterase inhibitor (product)\Product containing papaveretum (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Medicinal product categorized by disposition (product)\Product containing opioid receptor agonist (product)\Product containing papaveretum (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Papaveretum and scopolamine only product\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Medicinal product categorized by disposition (product)\Product containing opioid receptor agonist (product)\Product containing papaveretum (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing scopolamine (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Papaveretum and scopolamine only product\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing scopolamine (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing scopolamine (medicinal product)\Product containing scopolamine in parenteral dose form (medicinal product form)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Medicinal product categorized by structure\Product containing alkaloid (product)\...
• \Product containing opium alkaloid (product)\Product containing papaveretum (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\...
• \Papaveretum and scopolamine only product\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Product containing scopolamine (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Papaveretum and scopolamine only product\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Product containing scopolamine (medicinal product)\Product containing papaveretum and scopolamine (medicinal product)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Product containing scopolamine (medicinal product)\Product containing scopolamine in parenteral dose form (medicinal product form)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Product manufactured as parenteral dose form (product)\Product containing scopolamine in parenteral dose form (medicinal product form)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \médicament pour le système nerveux autonome\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing scopolamine (medicinal product)\...
• \Product containing papaveretum and scopolamine (medicinal product)\Papaveretum and scopolamine only product\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Product containing papaveretum and scopolamine (medicinal product)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
• \Product containing scopolamine in parenteral dose form (medicinal product form)\Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)\Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
3752376017	Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3752377014	Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3752378016	Papaveretum 15.4 mg/mL and scopolamine hydrobromide 400 microgram/mL solution for injection	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

Reference Sets

Canada English language reference set (foundation metadata concept)

GB English

US English

Back to Start